Cargando…

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?

OBJECTIVE: This matched-paired analysis explores disparities in health-related quality of life (QOL) and common toxicities between African American (AA) and white patients following proton therapy for prostate cancer at our institution. MATERIALS AND METHODS: A total of 1536 men with clinically loca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bryant, Curtis, Mendenhall, Nancy P., Henderson, Randal H., Nichols, Romaine C., Mendenhall, William M., Morris, Christopher G., Williams, Christopher, Su, Zhong, Li, Zuofeng, Hoppe, Bradford S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Articles: Genitourinary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876577/ https://www.ncbi.nlm.nih.gov/pubmed/24710124 http://dx.doi.org/10.1097/COC.0000000000000050

Ejemplares similares

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

Insurance Approval for Definitive Proton Therapy for Prostate Cancer
por: Mendenhall, William M., et al.
Publicado: (2021)

Proton therapy in the management of non-Hodgkin lymphoma
por: Sachsman, Suzanne, et al.
Publicado: (2015)

Consensus Statement on Proton Therapy for Prostate Cancer
por: Bryant, Curtis M., et al.
Publicado: (2021)

What men want: Results from a national survey on decision making for prostate cancer treatment and research participation
por: Mendenhall, Nancy P., et al.
Publicado: (2021)

Normal tissue complication probability models for prospectively scored late rectal and urinary morbidity after proton therapy of prostate cancer
por: Pedersen, Jesper, et al.
Publicado: (2021)

Analysis of Gastrointestinal Toxicity in Patients Receiving Proton Beam Therapy for Prostate Cancer: A Single-Institution Experience
por: Lee, Howard J., et al.
Publicado: (2018)

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer
por: Vargas, Carlos E., et al.
Publicado: (2018)

Complete testicular infarction secondary to epididymoorchitis and pyocele
por: Ramjit, Amit, et al.
Publicado: (2020)

Five-Year Prospective Observational Study of African-American Men on Active Surveillance for Prostate Cancer Demonstrates Race Is Not Predictive of Oncologic Outcomes
por: Pincus, Joshua, et al.
Publicado: (2022)

Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors
por: Holtzman, Adam L., et al.
Publicado: (2019)

Extragastrointestinal stromal tumor presenting as an exophytic prostatic mass
por: Nguyen Thanh, Thao, et al.
Publicado: (2020)

Case series: Diffusion weighted MRI appearance in prostatic abscess
por: Singh, Paramjeet, et al.
Publicado: (2011)

Multimodality approach to imaging giant multilocular cystadenoma of the prostate: A rare entity
por: El-Asmar, Jose M., et al.
Publicado: (2019)

Giant multilocular prostatic cystadenoma, a diagnosis to consider in large pelvic male masses
por: Portugal Teixeira, Inês, et al.
Publicado: (2019)

Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T
por: Koo, Ji Hyun, et al.
Publicado: (2013)

Transformation of adenocarcinoma of prostate to squamous cell carcinoma following hormonal treatment: A case report and review of the literature
por: Lee, Jihyun
Publicado: (2019)

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes
por: Rutenberg, Michael S., et al.
Publicado: (2022)

Incidental vesicourachal diverticulum in a young female
por: Tan, Christopher, et al.
Publicado: (2020)

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer
por: Guzhva, Lidia, et al.
Publicado: (2019)

Transplant uretero-inguinal hernia resulting in urosepsis
por: Areda, Moustafa Abou, et al.
Publicado: (2018)

Long-term Outcomes from Proton Therapy for Sinonasal Cancers
por: Dagan, Roi, et al.
Publicado: (2021)

(11)C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities
por: Jethwa, Krishan R., et al.
Publicado: (2019)

Assessment of Polyethylene Glycol Hydrogel Spacer and Its Effect on Rectal Radiation Dose in Prostate Cancer Patients Receiving Proton Beam Radiation Therapy
por: Navaratnam, Anojan, et al.
Publicado: (2019)

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial
por: McDonald, Andrew M., et al.
Publicado: (2018)

Biexponential Apparent Diffusion Coefficients Values in the Prostate: Comparison among Normal Tissue, Prostate Cancer, Benign Prostatic Hyperplasia and Prostatitis
por: Liu, Xiaohang, et al.
Publicado: (2013)

Pulmonary Function after Proton Therapy for Hodgkin Lymphoma
por: O'steen, Lillie, et al.
Publicado: (2019)

A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis
por: Callan, Laura, et al.
Publicado: (2019)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
por: Bates, James E., et al.
Publicado: (2021)

Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams
por: Jin, Hosang, et al.
Publicado: (2011)

A comprehensive dosimetric study of Monte Carlo and pencil‐beam algorithms on intensity‐modulated proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
por: Oh, So Won, et al.
Publicado: (2018)

Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection
por: Park, Sung Yoon, et al.
Publicado: (2018)

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study
por: Kharod, Shivam M., et al.
Publicado: (2020)

Pictorial essay: Congenital anomalies of male urethra in children
por: Jana, Manisha, et al.
Publicado: (2011)

The Back Alley Revisited: Sepsis after Attempted Self-Induced Abortion
por: Saultes, Teresa A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lan02huqtt2ug6f639q0cjodc4